<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36428998</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>22</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>11</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Evaluation of the Hematological and Serum Biochemistry Parameters in the Pre-Symptomatic and Symptomatic Stages of ALS Disease to Support Early Diagnosis and Prognosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3569</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11223569</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease. Since there are no pathognomonic tests for ALS prognoses; clinical diagnoses of the disease take time and are usually difficult. Prognostic biomarkers are urgently needed for rapid and effective ALS prognoses. Male albino rats were divided into ten groups based on age: 0 (40-45 days old), A (70-75 days old), B (90-95 days old), C (110-115 days old), and D (130-135 days old). Each group was divided into two subgroups according to its mutation status: wild type (SOD1<sup>WT</sup>) or mutated (SOD1<sup>G93A</sup>). Serum biochemistry and hematological parameters were measured in 90 rats to evaluate possible biomarkers for faster ALS diagnoses and prognoses. Weight loss, cholesterol, creatinine, glucose, total bilirubin (TBIL), blood urine nitrogen (BUN), c-peptide, glucagon, PYY, white blood cell (WBC), lymphocyte (LYM), monocyte (MID), granulocyte (GRAN), red cell distribution width with standard deviation (RDW-SD), red cell distribution width with the coefficient of variation (RDW-CV), platelet (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and procalcitonin (PCT) levels were changed in the SOD1<sup>G93A</sup> rats compared to the SOD1<sup>WT</sup> rats independently from aging. For the first time in the literature, we showed promising hematological and serum biochemistry parameters in the pre-symptomatic and symptomatic stages of ALS by eliminating the effects of aging. Our results can be used for early diagnoses and prognoses of ALS, improving the quality of life and survival time of ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aydemir</LastName><ForeName>Duygu</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6449-2708</Identifier><AffiliationInfo><Affiliation>Department of Medical Biochemistry, School of Medicine, Koc University, Sariyer, Istanbul 34450, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ko&#xe7; University Research Center for Translational Medicine (KUTTAM), Sariyer, Istanbul 34450, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Surucu</LastName><ForeName>Selcuk</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anatomy, School of Medicine, Koc University, Sariyer, Istanbul 34450, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basak</LastName><ForeName>Ayse Nazli</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0001-6977-2517</Identifier><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory, NDAL-KUTTAM, School of Medicine, Ko&#xe7; University, Istanbul 34010, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulusu</LastName><ForeName>Nuriye Nuray</ForeName><Initials>NN</Initials><Identifier Source="ORCID">0000-0002-3173-1389</Identifier><AffiliationInfo><Affiliation>Department of Medical Biochemistry, School of Medicine, Koc University, Sariyer, Istanbul 34450, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ko&#xe7; University Research Center for Translational Medicine (KUTTAM), Sariyer, Istanbul 34450, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">early diagnosis</Keyword><Keyword MajorTopicYN="N">hematological parameters</Keyword><Keyword MajorTopicYN="N">pre-symptomatic</Keyword><Keyword MajorTopicYN="N">serum biochemistry</Keyword><Keyword MajorTopicYN="N">symptomatic</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>26</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36428998</ArticleId><ArticleId IdType="pmc">PMC9688239</ArticleId><ArticleId IdType="doi">10.3390/cells11223569</ArticleId><ArticleId IdType="pii">cells11223569</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bonafede R., Mariotti R. ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles. Front. Cell. Neurosci. 2017;11:80. doi: 10.3389/fncel.2017.00080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00080</ArticleId><ArticleId IdType="pmc">PMC5359305</ArticleId><ArticleId IdType="pubmed">28377696</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir D., Ulusu N.N. Importance of the Serum Biochemical Parameters as Potential Biomarkers for Rapid Diagnosis and Evaluating Preclinical Stage of ALS. Med. Hypotheses. 2020;141:109736. doi: 10.1016/j.mehy.2020.109736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109736</ArticleId><ArticleId IdType="pubmed">32315925</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell R.M., Simmons Z., Beard J.L., Stephens H.E., Connor J.R. Plasma Biomarkers Associated with ALS and Their Relationship to Iron Homeostasis. Muscle Nerve. 2010;42:95&#x2013;103. doi: 10.1002/mus.21625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21625</ArticleId><ArticleId IdType="pubmed">20544912</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., Coyle J.T. Abnormal Excitatory Amino Acid Metabolism in Amyotrophic Lateral Sclerosis. Ann. Neurol. 1990;28:18&#x2013;25. doi: 10.1002/ana.410280106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410280106</ArticleId><ArticleId IdType="pubmed">2375630</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., Grierson A.J., Ackerley S., Miller C.C.J. Role of Axonal Transport in Neurodegenerative Diseases. Annu. Rev. Neurosci. 2008;31:151&#x2013;173. doi: 10.1146/annurev.neuro.31.061307.090711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.31.061307.090711</ArticleId><ArticleId IdType="pubmed">18558852</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosengren L.E., Karlsson J.-E., Karlsson J.-O., Persson L.I., Wikkels&#xf8; C. Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF. J. Neurochem. 2002;67:2013&#x2013;2018. doi: 10.1046/j.1471-4159.1996.67052013.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1996.67052013.x</ArticleId><ArticleId IdType="pubmed">8863508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Carrero J.J., Zagai U., Evans M., Ingre C., Pawitan Y., Fang F. Blood Biomarkers and Prognosis of Amyotrophic Lateral Sclerosis. Eur. J. Neurol. 2020;27:2125&#x2013;2133. doi: 10.1111/ene.14409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14409</ArticleId><ArticleId IdType="pubmed">32557963</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu L.T., Bowser R. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2017;14:119&#x2013;134. doi: 10.1007/s13311-016-0503-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0503-x</ArticleId><ArticleId IdType="pmc">PMC5233638</ArticleId><ArticleId IdType="pubmed">27933485</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir D., Sarayloo E., Ulusu N.N. Rosiglitazone-Induced Changes in the Oxidative Stress Metabolism and Fatty Acid Composition in Relation with Trace Element Status in the Primary Adipocytes. J. Med. Biochem. 2019;39:267. doi: 10.2478/jomb-2019-0041.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/jomb-2019-0041</ArticleId><ArticleId IdType="pmc">PMC7955996</ArticleId><ArticleId IdType="pubmed">33746608</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir D., Simsek G., Ulusu N.N. Dataset of the Analyzing Trace Elements and Minerals via ICP-MS: Method Validation for the Mammalian Tissue and Serum Samples. Data Brief. 2020;29:105218. doi: 10.1016/j.dib.2020.105218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dib.2020.105218</ArticleId><ArticleId IdType="pmc">PMC7016227</ArticleId><ArticleId IdType="pubmed">32071990</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F., Ingre C., Roos P., Kamel F., Piehl F. Risk Factors for Amyotrophic Lateral Sclerosis. Clin. Epidemiol. 2015;7:181. doi: 10.2147/CLEP.S37505.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E., Fang F. Epidemiology of Amyotrophic Lateral Sclerosis: An Update of Recent Literature. Curr. Opin. Neurol. 2019;32:771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse van Mantgem M.R., van Eijk R.P.A., van der Burgh H.K., Tan H.H.G., Westeneng H.-J., van Es M.A., Veldink J.H., van den Berg L.H. Prognostic Value of Weight Loss in Patients with Amyotrophic Lateral Sclerosis: A Population-Based Study. J. Neurol. Neurosurg. Psychiatry. 2020;91:867&#x2013;875. doi: 10.1136/jnnp-2020-322909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322909</ArticleId><ArticleId IdType="pubmed">32576612</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C., Calvo A., Grassano M., Canosa A., Manera U., D&#x2019;Ovidio F., Bombaci A., Bersano E., Mazzini L., Mora G., et al. Early Weight Loss in Amyotrophic Lateral Sclerosis: Outcome Relevance and Clinical Correlates in a Population-Based Cohort. J. Neurol. Neurosurg. Psychiatry. 2019;90:666&#x2013;673. doi: 10.1136/jnnp-2018-319611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S.T., Steyn F.J., Huang L., Mantovani S., Pfluger C.M.M., Woodruff T.M., O&#x2019;Sullivan J.D., Henderson R.D., McCombe P.A. Altered Expression of Metabolic Proteins and Adipokines in Patients with Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 2015;357:22&#x2013;27. doi: 10.1016/j.jns.2015.06.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.06.053</ArticleId><ArticleId IdType="pubmed">26198021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazic S.E., Semenova E., Williams D.P. Determining Organ Weight Toxicity with Bayesian Causal Models: Improving on the Analysis of Relative Organ Weights. Sci. Rep. 2020;10:6625. doi: 10.1038/s41598-020-63465-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-63465-y</ArticleId><ArticleId IdType="pmc">PMC7170916</ArticleId><ArticleId IdType="pubmed">32313041</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharadwaj S., Ginoya S., Tandon P., Gohel T.D., Guirguis J., Vallabh H., Jevenn A., Hanouneh I. Malnutrition: Laboratory Markers vs Nutritional Assessment. Gastroenterol. Rep. 2016;4:gow013. doi: 10.1093/gastro/gow013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gastro/gow013</ArticleId><ArticleId IdType="pmc">PMC5193064</ArticleId><ArticleId IdType="pubmed">27174435</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Calvo A., Bovio G., Canosa A., Bertuzzo D., Galmozzi F., Cugnasco P., Clerico M., De Mercanti S., Bersano E., et al. Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine. JAMA Neurol. 2014;71:1134. doi: 10.1001/jamaneurol.2014.1129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1129</ArticleId><ArticleId IdType="pubmed">25048026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishida S., Hashimoto I., Seike T., Abe Y., Nakaya Y., Nakanishi H. Serum Albumin Levels Correlate with Inflammation Rather than Nutrition Supply in Burns Patients: A Retrospective Study. J. Med. Investig. 2014;61:361&#x2013;368. doi: 10.2152/jmi.61.361.</Citation><ArticleIdList><ArticleId IdType="doi">10.2152/jmi.61.361</ArticleId><ArticleId IdType="pubmed">25264055</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The Role of Mitochondria in Amyotrophic Lateral Sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#x1b0;&#x1a1;ng K., Nguy&#x1ec5;n L.T.H. Roles of Vitamin D in Amyotrophic Lateral Sclerosis: Possible Genetic and Cellular Signaling Mechanisms. Mol. Brain. 2013;6:16. doi: 10.1186/1756-6606-6-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-16</ArticleId><ArticleId IdType="pmc">PMC3641959</ArticleId><ArticleId IdType="pubmed">23570271</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin X., Wu P., Wen T., Jia R., Zhang R., Jin J., Hu F., Chen Q.Y., Dang J. Comparative Assessment of Blood Metal/Metalloid Levels, Clinical Heterogeneity, and Disease Severity in Amyotrophic Lateral Sclerosis Patients. Neurotoxicology. 2022;89:12&#x2013;19. doi: 10.1016/j.neuro.2022.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2022.01.003</ArticleId><ArticleId IdType="pubmed">35007622</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q., Hu W., Xu L., Luo H., Wang N., Zhang Q. Decreased Serum Creatinine Levels Predict Short Survival in Amyotrophic Lateral Sclerosis. Ann. Clin. Transl. Neurol. 2021;8:448&#x2013;455. doi: 10.1002/acn3.51299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51299</ArticleId><ArticleId IdType="pmc">PMC7886033</ArticleId><ArticleId IdType="pubmed">33449454</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanznaster D., Bruno C., Bourgeais J., Emond P., Zemmoura I., Lef&#xe8;vre A., Reynier P., Eymieux S., Blanchard E., Vourc&#x2019;h P., et al. Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis. Biomedicines. 2022;10:1307. doi: 10.3390/biomedicines10061307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10061307</ArticleId><ArticleId IdType="pmc">PMC9220134</ArticleId><ArticleId IdType="pubmed">35740329</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Khalik J., Yutuc E., Crick P.J., Gustafsson J.-&#xc5;., Warner M., Roman G., Talbot K., Gray E., Griffiths W.J., Turner M.R., et al. Defective Cholesterol Metabolism in Amyotrophic Lateral Sclerosis. J. Lipid Res. 2017;58:267&#x2013;278. doi: 10.1194/jlr.P071639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.P071639</ArticleId><ArticleId IdType="pmc">PMC5234729</ArticleId><ArticleId IdType="pubmed">27811233</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge J.C., Yu J., Sardi S.P., Shihabuddin L.S. Sterol Auto-Oxidation Adversely Affects Human Motor Neuron Viability and Is a Neuropathological Feature of Amyotrophic Lateral Sclerosis. Sci. Rep. 2021;11:803. doi: 10.1038/s41598-020-80378-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80378-y</ArticleId><ArticleId IdType="pmc">PMC7804278</ArticleId><ArticleId IdType="pubmed">33436868</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez De Aguilar J.-L. Lipid Biomarkers for Amyotrophic Lateral Sclerosis. Front. Neurol. 2019;10:284. doi: 10.3389/fneur.2019.00284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00284</ArticleId><ArticleId IdType="pmc">PMC6458258</ArticleId><ArticleId IdType="pubmed">31019485</ArticleId></ArticleIdList></Reference><Reference><Citation>Karajibani M., Montazerifar F., Hosseini R., Suni F., Dashipour A.R., Fadaaeimokhtarkanlo M. The Relationship Between Malnutrition and Liver Enzymes in Hospitalized Children in Zahedan: A Case-Control Study. Zahedan J. Res. Med. Sci. 2021;23 doi: 10.5812/zjrms.102994.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/zjrms.102994</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayanti S., Moretti R., Tiribelli C., Gazzin S. Bilirubin and Inflammation in Neurodegenerative and Other Neurological Diseases. Neuroimmunol. Neuroinflamm. 2020;7:92&#x2013;108. doi: 10.20517/2347-8659.2019.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.20517/2347-8659.2019.14</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Steyn F.J., Ngo S.T., Borges K. CNS Glucose Metabolism in Amyotrophic Lateral Sclerosis: A Therapeutic Target? Cell Biosci. 2021;11:14. doi: 10.1186/s13578-020-00511-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00511-2</ArticleId><ArticleId IdType="pmc">PMC7798275</ArticleId><ArticleId IdType="pubmed">33431046</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones A.G., Hattersley A.T. The Clinical Utility of C-peptide Measurement in the Care of Patients with Diabetes. Diabet. Med. 2013;30:803&#x2013;817. doi: 10.1111/dme.12159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.12159</ArticleId><ArticleId IdType="pmc">PMC3748788</ArticleId><ArticleId IdType="pubmed">23413806</ArticleId></ArticleIdList></Reference><Reference><Citation>Karra E., Chandarana K., Batterham R.L. The Role of Peptide YY in Appetite Regulation and Obesity. J. Physiol. 2009;587:19&#x2013;25. doi: 10.1113/jphysiol.2008.164269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2008.164269</ArticleId><ArticleId IdType="pmc">PMC2670018</ArticleId><ArticleId IdType="pubmed">19064614</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartipy P., Loskutoff D.J. Monocyte Chemoattractant Protein 1 in Obesity and Insulin Resistance. Proc. Natl. Acad. Sci. USA. 2003;100:7265&#x2013;7270. doi: 10.1073/pnas.1133870100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1133870100</ArticleId><ArticleId IdType="pmc">PMC165864</ArticleId><ArticleId IdType="pubmed">12756299</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco A., Chiesa M.R., Da Prato I., Romanelli A.M., Dolciotti C., Cavallini G., Masciandaro S.M., Scilingo E.P., Del Carratore R., Bongioanni P. Using Blood Data for the Differential Diagnosis and Prognosis of Motor Neuron Diseases: A New Dataset for Machine Learning Applications. Sci. Rep. 2021;11:3371. doi: 10.1038/s41598-021-82940-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82940-8</ArticleId><ArticleId IdType="pmc">PMC7873306</ArticleId><ArticleId IdType="pubmed">33564045</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc5;berg M., Nyberg J., Robertson J., Kuhn G., Schi&#xf6;ler L., Nissbrandt H., Waern M., Tor&#xe9;n K. Risk Factors in Swedish Young Men for Amyotrophic Lateral Sclerosis in Adulthood. J. Neurol. 2018;265:460&#x2013;470. doi: 10.1007/s00415-017-8719-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8719-1</ArticleId><ArticleId IdType="pmc">PMC5834569</ArticleId><ArticleId IdType="pubmed">29285652</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q.-Q., Chen Y., Cao B., Ou R.W., Zhang L., Hou Y., Gao X., Shang H. Blood Hemoglobin A1c Levels and Amyotrophic Lateral Sclerosis Survival. Mol. Neurodegener. 2017;12:69. doi: 10.1186/s13024-017-0211-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0211-y</ArticleId><ArticleId IdType="pmc">PMC5609007</ArticleId><ArticleId IdType="pubmed">28934974</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Lee J.D., Woodruff T.M., Henderson R.D. The Peripheral Immune System and Amyotrophic Lateral Sclerosis. Front. Neurol. 2020;11:279. doi: 10.3389/fneur.2020.00279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00279</ArticleId><ArticleId IdType="pmc">PMC7186478</ArticleId><ArticleId IdType="pubmed">32373052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Gascon R., Miller R.G., Gelinas D.F., Mass J., Hadlock K., Jin X., Reis J., Narvaez A., McGrath M.S. Evidence for Systemic Immune System Alterations in Sporadic Amyotrophic Lateral Sclerosis (SALS) J. Neuroimmunol. 2005;159:215&#x2013;224. doi: 10.1016/j.jneuroim.2004.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2004.10.009</ArticleId><ArticleId IdType="pubmed">15652422</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I.M., Chen A., Zheng Y., Kosaras B., Tsiftsoglou S.A., Vartanian T.K., Brown R.H., Carroll M.C. T Lymphocytes Potentiate Endogenous Neuroprotective Inflammation in a Mouse Model of ALS. Proc. Natl. Acad. Sci. USA. 2008;105:17913&#x2013;17918. doi: 10.1073/pnas.0804610105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804610105</ArticleId><ArticleId IdType="pmc">PMC2581614</ArticleId><ArticleId IdType="pubmed">18997009</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce C.N., Larson D.F. Inflammatory Cytokine Inhibition of Erythropoiesis in Patients Implanted with a Mechanical Circulatory Assist Device. Perfusion. 2005;20:83&#x2013;90. doi: 10.1191/0267659105pf793oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0267659105pf793oa</ArticleId><ArticleId IdType="pubmed">15918445</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir D., &#xd6;zta&#x15f;c&#x131; B., Barlas N., Ulusu N.N. Effects of Butylparaben on Antioxidant Enzyme Activities and Histopathological Changes in Rat Tissues. Arch. Ind. Hyg. Toxicol. 2019;70:315&#x2013;324. doi: 10.2478/aiht-2019-70-3342.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/aiht-2019-70-3342</ArticleId><ArticleId IdType="pubmed">32623865</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir D., Hashemkhani M., Acar H.Y., Ulusu N.N. Evaluation of the Biocompatibility of the GSH-Coated Ag2S Quantum Dots in Vitro: A Perfect Example for the Non-Toxic Optical Probes. Mol. Biol. Rep. 2020;47:4117&#x2013;4129. doi: 10.1007/s11033-020-05522-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05522-3</ArticleId><ArticleId IdType="pubmed">32436042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozcan M., Aydemir D., Bacanl&#x131; M., Anlar H.G., Ulusu N.N., Aksoy Y. Protective Effects of Antioxidant Chlorophyllin in Chemically Induced Breast Cancer Model In Vivo. Biol. Trace Elem. Res. 2021;199:4475&#x2013;4488. doi: 10.1007/s12011-021-02585-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-021-02585-6</ArticleId><ArticleId IdType="pubmed">33624221</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir D., Karabulut G., &#x15e;im&#x15f;ek G., Gok M., Barlas N., Ulusu N.N. Impact of the Di(2-Ethylhexyl) Phthalate Administration on Trace Element and Mineral Levels in Relation of Kidney and Liver Damage in Rats. Biol. Trace Elem. Res. 2018;186:474&#x2013;488. doi: 10.1007/s12011-018-1331-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-018-1331-0</ArticleId><ArticleId IdType="pubmed">29654488</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir D., Ulusu N.N. Comment on the: Molecular mechanism of CAT and SOD activity change under MPA-CdTe quantum dots induced oxidative stress in the mouse primary hepatocytes (Spectrochim Acta A Mol Biomol Spectrosc. 2019 Sep 5; 220:117104) Spectrochim. Acta-A Mol. Biomol. Spectrosc. 2020;229:117792. doi: 10.1016/j.saa.2019.117792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.saa.2019.117792</ArticleId><ArticleId IdType="pubmed">31865110</ArticleId></ArticleIdList></Reference><Reference><Citation>Fracchiolla G., Laghezza A., Piemontese L., Tortorella P., Mazza F., Montanari R., Pochetti G., Lavecchia A., Novellino E., Pierno S., et al. New 2-Aryloxy-3-Phenyl-Propanoic Acids as Peroxisome Proliferator-Activated Receptors &#x3b1;/&#x3b3; Dual Agonists with Improved Potency and Reduced Adverse Effects on Skeletal Muscle Function. J. Med. Chem. 2009;52:6382&#x2013;6393. doi: 10.1021/jm900941b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm900941b</ArticleId><ArticleId IdType="pubmed">19775169</ArticleId></ArticleIdList></Reference><Reference><Citation>Camerino G.M., Fonzino A., Conte E., de Bellis M., Mele A., Liantonio A., Tricarico D., Tarantino N., Dobrowolny G., Musar&#xf2; A., et al. Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in Search of New Therapeutic Options. Sci. Rep. 2019;9:3185. doi: 10.1038/s41598-019-39676-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39676-3</ArticleId><ArticleId IdType="pmc">PMC6395744</ArticleId><ArticleId IdType="pubmed">30816241</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>